Solving Challenges in Contraceptive Discovery and Innovation


SSR_Gates.png


Contraception plays a vital role in family planning and improving health and economic opportunities for women.  Yet a lack of appropriate choice and access means that the contraceptive needs of hundreds of millions of couples wishing to avoid pregnancy go unmet in both developed and developing countries.

Thanks to the generous support of the Bill and Melinda Gates Foundation, the Society for the Study of Reproduction in partnership the International Society of Endocrinology (ISE) is excited to present a series of virtual symposia focused on novel contraceptive discovery.

The goal of this event is to stimulate new research and novel approaches to solving the challenges of innovation and creating increased choice, particularly in non-hormonal contraceptives.  We look forward to welcoming participants from all areas of reproductive biology research and all geographic regions to engage in exploring challenges and creating opportunities for new innovations in this important and underrepresented field of study.

We look forward to welcoming participants from all areas of reproductive biology research and all geographic regions to engage in exploring challenges and creating opportunities for new innovations in this important and underrepresented field of study.

Agenda 

E-Poster Sessions

E-Poster Sessions
The e-poster hall will be open 24-hrs a day from October 12th -19th. will be hosting the posters online using our new e-poster platform which will allow viewers to send questions to poster authors and view the video/audio narratives with each poster.

Wednesday, September 30th 

Novel Contraceptives Targeting Sperm Development and Function - 4:00-6:00 PM (EST)

View Webinar Recording HERE 


4:00 -
Keynote Speaker: Martin Matzuk, Baylor College of Medicine, USA
DNA-Encoded Chemistry Technology and Functional Genomics for Contraception Research

4:45 -
Laura Giojalas, National University of Cordoba, Argentina 
Sperm Chemotaxis And Its Potential Application For New Contraceptive Development

5:00-
Mariano Buffone, Institute of Biology and Experimental Medicine, Argentina 
Sperm Acrosome Reaction and Capacitation and The Potential Application For New Contraceptive Development

5:15 - 
Aaron Crapster, Vibliome Therapeutics Stanford University, USA
HIPK4-Selective Inhibitors for Male Contraception

5:30 - Alan Andrew Silva, São Paulo State University, Brazil 
The Roles of Epididymal Protease Inhibitor (EPPIN) N-Terminal and C-Terminal Regions on The Regulation of Mouse Sperm Motility

5:40 - Noemia Mariani, São Paulo State University, Brazil 
Recombinant Seminal Vesicle-Secreted Protein SVS2 Inhibits the Motility of Mouse Spermatozoa in vitro


5:50 - Nongnuj Tanphaichitr, University of Ottawa, Canada 
Potential Use of LL-37/17BIPHE2 as Vaginal Spermicides/Microbicides

Wednesday, October 7th 

Male Contraceptive Development Targeting Spermatogenesis - 4:00-6:00 PM (EST)

View Webinar Recording HERE 


4:00 - Keynote Speaker: Patricia Cuasnicú
, Institute of Biology and Experimental Medicine, Argentina
CRISP Proteins as Novel Targets for Male Contraceptive Development

4:45 - Gustavo Blanco, Kansas University Medical Center, USA
Targeting Na,K-ATPase Alpha 4 for Male Contraception

5:00 - John Amory, University of Washington, USA 
Inhibition of Retinoic Acid Biosynthesis as A Target for Male Contraception

5:15 - Wei Yan, David Geffen School of Medicine at UCLA, USA
SD-1 Is A Reversible, Non-Hormonal Male Contraceptive Agent

5:30 - Asifu Basiru, University of Ilorin, Nigeria
Waltheria Indica Linn. Root Exhibits Male Contraceptive Effect Through Inhibition of Androgensis In Male Wistar Rats

5
:40 - Haiqi Chen, Broad Institute of MIT and Harvard, USA
Testicular Spatial Transcriptome Atlas Reveals Functional Dynamics in Gene Programs During Mammalian Spermatogenesis

5:50 - Maximilian Lyon, Washington University School of Medicine
The Sperm-Specific Potassium Channel SLO3 is a Target for Contraceptive Development

Wednesday, October 14th

Non-Hormonal Female Contraceptive Strategies - 4:00-6:00 PM (EST)

View Recording HERE

4:00 Keynote Speaker: Diane Duffy
, Eastern Virginia Medical School, USA
Ovulatory Angiogenesis as a Target for Novel Contraceptive Development

4:45 - Shuo Xiao
, Rutgers University, USA
3D In Vitro Follicle Culture as An Effective Model for Contraceptive Discovery

5:00 - Marina Peluffo, Centro de Investigaciones Endocrinológicas (CEDIE), Argentina
Chemokines and Their Potential Application for New Female Contraceptive Development

5:15 - Sergio Romero, by Universidad Peruana Cayetano Heredia, Peru            
Oocyte Maturation Mechanism.  Potential Targets for Contraception

5:30 - Doan Thao Dinh, University of Adelaide, Australia
Unique Molecular Mechanism of Progesterone Receptor in Granulosa Cells during Ovulation

5:40 - Emily Harris, Washington State University, USA     
Progesterone Signaling in the Oviduct Epithelial Cells is Required for Normal Embryo Transport and Development

5:50 - Jiyang Zhang, Northwestern University, USA
Mouse Ovarian Follicles from Encapsulated in Vitro Follicle Growth (eIVFG) Preserve Ovulation Molecular Signatures in Vivo

6:15-7:30 Virtual Happy Hour
Join us for an informal networking event where you can get to know attendees from around the world. Bring your beverage of choice and mingle in randomly assigned breakout rooms.

Session Recordings
Missed a session? You can now view them online!  Recordings are available for SSR Members only.  

Awards

Three E/MCR awards of $1,200 for travel support to the 2021 SSR meeting will be offered.  One presenter whose abstract was selected for an oral talk will be selected from each symposium session for best abstract/ presentation. The SSR Contraception Program Committee will select finalists on the basis of an evaluation of the abstracts submitted for competition. Each award will be announced at the end of each symposium.